NRIX.NASDAQNurix Therapeutics, INC

Form 4: Nurix Therapeutics' Chief Legal Officer, Christine Ring, Executes Stock Option and Sells Shares

Sentiment:

SEC Form 4 Filing

📋All filings for Nurix Therapeutics, INC
🔒Login to Follow

Christine Ring, Chief Legal Officer of Nurix Therapeutics, exercised stock options and sold shares on June 3, 2024, according to a Form 4 filing with the SEC.

Summary

  • On June 3, 2024, Christine Ring, the Chief Legal Officer of Nurix Therapeutics, exercised stock options to acquire 1,596 shares of common stock at a price of $1.86 per share.
  • Simultaneously, Ring sold 1,596 shares of common stock at a weighted average price of $17.0131, with prices ranging from $17.00 to $17.06.
  • These transactions were executed under a pre-arranged Rule 10b5-1 trading plan.
  • Following these transactions, Ring directly owns 19,838 shares of Nurix Therapeutics common stock and holds options for 98,470 shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of insider transactions and provides transparency to investors regarding the actions of company executives.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal given the relatively small number of shares involved.

Key Dates

DateDescription
09/09/2020Option vested as to 1/4 of the total shares.
08/09/2023Option fully vested.
06/03/2024Earliest transaction date: Exercise of stock options and sale of shares.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.